| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Kyu-Huok Lee CEO | KRX SM Exchange | KR7017180001 ISIN |
| KR Country | 291 Employees | 27 Dec 2017 Last Dividend | 14 May 2020 Last Split | - IPO Date |
MYUNGMOON Pharm Co., Ltd is a distinguished pharmaceutical company that has carved a niche for itself both within South Korea and on the international stage since its inception in 1983. Headquartered in Seoul, South Korea, the company is actively involved in a wide range of pharmaceutical activities that encompass the research, development, production, and distribution of a vast array of pharmaceutical products. The company's dedication to advancing healthcare through innovation is evident in its comprehensive product portfolio, which caters to a variety of therapeutic areas. MYUNGMOON Pharm is dedicated to improving patient care and outcomes, positioning itself as a key player in the pharmaceutical industry.
MYUNGMOON Pharm Co., Ltd offers an extensive range of pharmaceutical products and services catering to various healthcare needs. These include: